These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 18389878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [To treat or not to treat with statins patients with chronic heart failure?].
    Hradec J.
    Vnitr Lek; 2009 Sep; 55(9):802-7. PubMed ID: 19785380
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
    Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA Study Group.
    J Am Coll Cardiol; 2009 Nov 10; 54(20):1850-9. PubMed ID: 19892235
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA.
    Future Cardiol; 2009 May 10; 5(3):231-6. PubMed ID: 19656039
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.
    Clin Ther; 2007 Nov 10; 29(11):2385-94. PubMed ID: 18158079
    [Abstract] [Full Text] [Related]

  • 9. Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.
    Burmeister JE, Miltersteiner DR, Campos BM.
    J Nephrol; 2009 Nov 10; 22(1):83-9. PubMed ID: 19229822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J, Sullivan D, Smith M.
    Am J Cardiol; 2008 Dec 15; 102(12):1654-62. PubMed ID: 19064019
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M, Averna M, Missault L, Vaverkova H, Viigimaa M, Massaad R, Vandormael K, Johnson-Levonas AO, Brudi P.
    Int J Clin Pract; 2009 Apr 15; 63(4):547-59. PubMed ID: 19222610
    [Abstract] [Full Text] [Related]

  • 14. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS, Milionis HJ, Elisaf MS.
    Am J Cardiovasc Drugs; 2010 Apr 15; 10(1):11-28. PubMed ID: 20104931
    [Abstract] [Full Text] [Related]

  • 15. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R.
    Ther Adv Cardiovasc Dis; 2009 Aug 15; 3(4):309-15. PubMed ID: 19460829
    [Abstract] [Full Text] [Related]

  • 16. The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).
    O'Keefe JH, Carter MD, Lavie CJ, Bell DS.
    Postgrad Med; 2009 May 15; 121(3):113-8. PubMed ID: 19491548
    [Abstract] [Full Text] [Related]

  • 17. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P, CORONA Study Group.
    Eur Heart J; 2012 Sep 15; 33(18):2290-6. PubMed ID: 22513778
    [Abstract] [Full Text] [Related]

  • 18. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
    Fonseca FA, Izar MC.
    Expert Rev Cardiovasc Ther; 2009 Sep 15; 7(9):1041-56. PubMed ID: 19764857
    [Abstract] [Full Text] [Related]

  • 19. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.
    Ann Intern Med; 2010 Apr 20; 152(8):I34. PubMed ID: 20404365
    [No Abstract] [Full Text] [Related]

  • 20. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L.
    Circ Heart Fail; 2011 Mar 20; 4(2):145-52. PubMed ID: 21216833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.